Laronde banks $440M to ramp up RNA-based meds that could turn cells into protein factories
Laronde launched out of Flagship Labs this year with a lofty vision: to deliver as many as 100 new RNA medicines over the next 10 years....
Laronde banks $440M to ramp up RNA-based meds that could turn cells into protein factories
Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company
BiotechBayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
Vividion Therapeutics Files for IPO
Tempest and Millendo Announce Stockholder Approval of Merger
Lyell Immunopharma Announces Pricing of Initial Public Offering